We are live on
!
Find out more
Pacific Biosciences
PACB
PACB
107 hedge funds and large institutions have $281M invested in Pacific Biosciences in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
1% more funds holding
Funds holding: 106 → 107 (+1)
0.05% more ownership
Funds ownership: 70.92% → 70.97% (+0.05%)
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
31% less capital invested
Capital invested by funds: $406M → $281M (-$125M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
99% less call options, than puts
Call options by funds: $5K | Put options by funds: $722K
Holders
107
Holders Change
+1
Holders Change %
+0.94%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
17
Increased
34
Reduced
38
Closed
16
Calls
$5K
Puts
$722K
Net Calls
-$717K
Net Calls Change
+$3.13M
Top Buyers
Top Sellers
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
-$77.8M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$10M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.61M |
| 4 |
Morgan Stanley
New York
|
-$2.71M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$2.05M |
